Citation: Ljc. Vanwarmerdam et al., DOSE INDIVIDUALIZATION IN CANCER-CHEMOTHERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS, Cancer research, therapy & control, 4(4), 1995, pp. 277-291
Authors:
TASHIRO S
WANG ZW
KOTOMURA N
EGUCHI M
NIWA O
UEDA K
KAMADA N
Citation: S. Tashiro et al., NUCLEAR PROTEINS BINDING TO THE RECOMBINATION HOT-SPOT REGION OF THE RETINOIC ACID RECEPTOR-ALPHA GENE, Cancer research, therapy & control, 4(4), 1995, pp. 293
Citation: H. Nagase et al., ENHANCING EFFECT OF METALLOTHIONEIN ON TUMOR-CELL INVASION IN-VITRO, Cancer research, therapy & control, 4(4), 1995, pp. 301
Citation: A. Aviles et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF INFECTION AND SEVERE GRANULOCYTOPENIA, Cancer research, therapy & control, 4(3), 1995, pp. 157-161
Citation: Rm. Nagler et al., IRRADIATION-INDUCED INJURY TO THE HSG HUMAN CELL-LINE - IN-VITRO MODEL FOR REPRODUCTIVE CELL-DEATH IN MAJOR SALIVARY-GLANDS, Cancer research, therapy & control, 4(3), 1995, pp. 173-181
Authors:
REINTGEN D
ALBERTINI J
MILIOTES G
BERMAN C
CRUSE CW
FENSKE N
GLASS F
PAC CP
WANG XN
WELLS K
RAPAPORT D
DECONTI R
MESSINA J
HELLER R
Citation: D. Reintgen et al., THE ACCURATE STAGING AND MODERN-DAY TREATMENT OF MALIGNANT-MELANOMA, Cancer research, therapy & control, 4(3), 1995, pp. 183-197
Authors:
SATOH H
ISHIKAWA H
FUNAYAMA Y
YAZAWA T
OGATA T
HASEGAWA S
Citation: H. Satoh et al., COMBINATION CYTOTOXIC EFFECTS OF 5-FLUOROURACIL AND CARBOPLATIN AGAINST HUMAN LUNG-CANCER CELL-LINES, Cancer research, therapy & control, 4(3), 1995, pp. 199-202
Authors:
PAUKOVITS WR
MOSER MH
PAUKOVITS JB
KNEISSL S
ROSEBROCK U
GIESEKE T
BINDER KA
KARLIC HI
Citation: Wr. Paukovits et al., THE MYELOSTIMULATORY DEKAPEPITDE (PEEDCK)(2) INDUCES PROLIFERATION INPLURIPOTENT HEMATOPOIETIC STEM-CELLS IN-VIVO AND INCREASES LEUKOCYTE AND PLATELET PRODUCTION - A POSSIBLE ALTERNATIVE FOR RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS, Cancer research, therapy & control, 4(3), 1995, pp. 203-209
Citation: Ce. Andrademena et Ej. Ramirezlizardo, CD4-CELLS ARE REQUIRED FOR TUMOR-REGRESSION INDUCED BY POLY-I-POLY-C ADMINISTRATION( T), Cancer research, therapy & control, 4(3), 1995, pp. 211-216
Authors:
GARRETT E
ROWE SM
COUGHLAN SJ
HORAN R
MCLINDEN J
CARNEY DN
FANNING M
KIEBACK DG
HEADON DR
Citation: E. Garrett et al., MENDELIAN INHERITANCE OF A TAQI RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM DUE TO AN INSERTION IN THE HUMAN PROGESTERONE-RECEPTOR GENE AND ITS ALLELIC IMBALANCE IN BREAST-CANCER, Cancer research, therapy & control, 4(3), 1995, pp. 217-222
Authors:
MERK K
LENNETTE E
HOLM G
JOHANSSON B
MASUCCI G
GRIMFORS G
KLEIN G
BJORKHOLM M
Citation: K. Merk et al., ANTIBODIES TO EPSTEIN-BARR-VIRUS IN RELATION TO CLINICAL CHARACTERISTICS OF UNTREATED PATIENTS WITH HODGKINS-DISEASE, Cancer research, therapy & control, 4(3), 1995, pp. 223-229
Citation: Nj. Nusbaum et Jc. Gonzalez, FAILURE TO DETECT ASYMPTOMATIC COLORECTAL-CANCER - A SINGLE INSTITUTION EXPERIENCE, Cancer research, therapy & control, 4(3), 1995, pp. 237-240
Citation: Dg. Mcintosh et al., HIGH-DOSE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS A SALVAGE REGIMEN FOR OVARIAN-CANCER, Cancer research, therapy & control, 4(2), 1994, pp. 77-80
Authors:
TRIZNA Z
LEE JJ
HSU TC
BENNER S
FRITSCHE HA
PANG A
HONG WK
Citation: Z. Trizna et al., PROTECTIVE EFFECTS OF IN-VIVO 13-CIS-RETINOIC ACID TREATMENT AGAINST MUTAGEN-INDUCED GENETIC-DAMAGE, Cancer research, therapy & control, 4(2), 1994, pp. 81-85
Citation: Ww. Au et al., CHROMOSOME AND ASSOCIATED CHANGES IN MALIGNANT TRANSFORMATION OF MOUSE MAMMARY CELLS, Cancer research, therapy & control, 4(2), 1994, pp. 109-118
Authors:
THOMAS TE
PHILLIPS GL
HUMPHRIES RK
HORSMAN DE
GASCOYNE RD
ABRAHAM SJR
LITTLE MTE
LANSDORP PM
Citation: Te. Thomas et al., POSITIVE SELECTION OF CD34(-MARROW FOR INDIRECT PURGING OF NON-HODGKINS-LYMPHOMA CELLS() CELLS FROM HUMAN BONE), Cancer research, therapy & control, 4(2), 1994, pp. 119-128
Citation: I. Camby et R. Kiss, CLONE ARCHITECTURE AND GROWTH-CHARACTERIZATION IN CHEMORADIOSENSITIVE, CHEMORESISTANT, RADIORESISTANT AND CHEMORADIORESISTANT NEOPLASTIC CELL-LINES, Cancer research, therapy & control, 4(2), 1994, pp. 129-141
Citation: Ja. Chen et Ed. Ball, DETECTION OF RAS ONCOGENE POINT MUTATIONS IN HL-60 PROMYELOCYTIC LEUKEMIA-CELLS USING A 2-STEP POLYMERASE CHAIN-REACTION - RELEVANCE TO MONITORING OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID-LEUKEMIA, Cancer research, therapy & control, 4(2), 1994, pp. 143-148
Authors:
MILLER AM
CONLEY NS
ALLEN B
HOOVER DL
WEINER RS
Citation: Am. Miller et al., BLEOMYCIN-INDUCED DIFFERENTIATION OF A HUMAN MONOBLAST CELL-LINE U937, Cancer research, therapy & control, 4(2), 1994, pp. 149-153
Citation: Ti. Mughal et K. Oneill, COMBINATION OF ONDANSETRON AND LORAZEPAM AS PROPHYLAXIS OF CHEMOTHERAPY ASSOCIATED EMESIS, Cancer research, therapy & control, 4(2), 1994, pp. 155-156
Citation: Sd. Weitman et Ba. Kamen, COMBINATION CHEMOTHERAPY A CASE OF THE NEW MATH - WHEN AN ADDITION INA SUBTRACTION, Cancer research, therapy & control, 4(1), 1994, pp. 1-2